Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report
Joseph F. Arboleda‐Velásquez(Massachusetts Eye and Ear Infirmary), Yakeel T. Quiroz(Harvard University), Pierre N. Tariot(Banner Health), Matthew A. Lalli(Icahn School of Medicine at Mount Sinai), Yi Su(University of Electronic Science and Technology of China), Pradeep Thiyyagura(Alzheimer's Association), Aaron P. Schultz(Harvard University), Justin S. Sanchez(Harvard University), Kenneth S. Kosik(University of California, Santa Barbara), Ana Baena(Washington University in St. Louis), Daniel Norton(Gordon College), Xiaowu Gai(Massachusetts Eye and Ear Infirmary), Kahira L. Saez‐Torres(Massachusetts Eye and Ear Infirmary), Francisco Lopera(Universidad de Antioquia), Kaj Blennow(Sahlgrenska University Hospital), David Aguillón(Universidad de Antioquia), Gyungah Jun(Boston University), Michael O’Hare, Matthew J. Huentelman(Translational Genomics Research Institute), Jianling Ji(University of Southern California), Edmarie Guzmán‐Vélez(Boston University), Rebecca Reiman(Translational Genomics Research Institute), Silvia Ríos‐Romenets(Montreal General Hospital), David Leyton-Cifuentes(Massachusetts Eye and Ear Infirmary), Eric M. Reiman(Alzheimer's Association), John B. Miller(Center for Cancer Research), Leo A. Kim(Massachusetts Eye and Ear Infirmary), Margarita Giraldo(Universidad de Antioquia), Ji Luo(Alzheimer's Association), Claudia Mariño(Massachusetts Eye and Ear Infirmary), Dhanesh Amarnani(Massachusetts Eye and Ear Infirmary), Santiago Delgado‐Tirado(Clínica Rementería), Juliana Acosta‐Uribe(University of California, Santa Barbara), Natalia Chmielewska(Boston College), Enmanuelle Pardilla‐Delgado(Harvard University), Henrik Zetterberg(University of Wisconsin–Madison), Arabiye Artola(Harvard University), Keith A. Johnson(Brigham and Women's Hospital), Kewei Chen(Good Samaritan Medical Center), Li Shen(Children's Hospital of Los Angeles), Yinghua Chen(Shanghai East Hospital), Moiz Bootwalla(Children's Hospital of Los Angeles), Marcus Naymik(Translational Genomics Research Institute), Reisa A. Sperling(Harvard University)
Cited by 606
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k